PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-1.63%)
As of: Oct 1, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Operating Expenses (2010 - 2026)

Updated

PharmaCyte Biotech's Operating Expenses came in at $1.01 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), up 18.7% from $848,305 a year earlier but down 59.9% from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Operating Expenses (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jul 31, 2026, PharmaCyte Biotech reported Operating Expenses of $7.01 million, up 77.2% year-over-year; for FY2026 (ended Apr 30, 2026), it was $6.85 million, up 56.6% from FY2025.

  • Operating Expenses carries a five-year compound annual growth rate of 13.6% (FY2021 to FY2026).
  • Going back by fiscal year, Operating Expenses was $4.38 million in FY2025 (-48.6%), $8.52 million in FY2024 (+32.0%), $6.46 million in FY2023 (+47.0%) and $4.39 million in FY2022 (+21.2%).
  • The five-year range for quarterly Operating Expenses is $848,305 (fiscal Q1 2026) to $3.17 million (fiscal Q4 2024).
  • Year-over-year, Operating Expenses has increased for four consecutive quarters, with growth averaging 16.8% over the last eight quarters.
  • The fastest year-over-year change in Operating Expenses over five years came in fiscal Q4 2024 (growth of 250.5%), and the weakest in fiscal Q4 2025 (a decline of 67.1%).
  • Business Quant data shows PMCB's Operating Expenses at $2.51 million (Q4 2026), $2.12 million (Q3 2026) and $1.38 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 PharmaCyte Biotech 4.40 Mn 4.40 Mn - 1.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 1.01 Mn
Apr 30, 2026 2.51 Mn
Jan 31, 2026 2.12 Mn
Oct 31, 2025 1.38 Mn
Jul 31, 2025 848,305.00
Apr 30, 2025 1.04 Mn
Jan 31, 2025 960,252.00
Oct 31, 2024 1.11 Mn
Jul 31, 2024 1.27 Mn
Apr 30, 2024 3.17 Mn
Jan 31, 2024 1.87 Mn
Oct 31, 2023 1.41 Mn
Jul 31, 2023 2.08 Mn
Apr 30, 2023 903,283.00
Jan 31, 2023 1.55 Mn
Oct 31, 2022 2.32 Mn
Jul 31, 2022 1.68 Mn
Apr 30, 2022 1.51 Mn
Jan 31, 2022 856,119.00
Oct 31, 2021 1.00 Mn
API Access

PharmaCyte Biotech Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=PMCB&period=max&api_key=YOUR_API_KEY